Shijiazhuang, China – From March 4 to March 5, MicroPort NeuroTech（Shanghai）Co., Ltd. ("MicroPort® NeuroTech") hosted WILLIS® Intracranial Stent Graft System ("WILLIS®") Academic Symposium & the Standing Committee meeting of Hebei Vascular Health and Technology Association Cerebral Vascular Intervention Special Committee. Several local neurovascular interventional specialists attended the symposium and shared the experience and technique in using WILLIS®.
The symposium was chaired by Director Lin Zhao of the Second Hospital of Hebei Medical University, covering topics of the application of WILLIS®, clinical experience in using WILLIS®, the learning curve of WILLIS®, the endovascular treatment of blood blister-like aneurysm, and the application of endovascular graft exclusion ("EVGE") in treating ophthalmic arterysegmental aneurysm. Professor Minghua Li of Shanghai Sixth People's Hospital, who is the inventor of WILLIS® EVGE, and Professor Chuhan Jiang of Beijing Tian Tan Hospital were invited to share their clinical experience in using WILLIS® to enhance the attendees' understanding in WILLIS®, and meanwhile they had active interactions with the attendees regarding WILLIS®'s indications. Professor Minghua Li fully recognized the development of the neurovascular interventional industry in Hebei Province and showed his gratitude to MicroPort® NeuroTech for providing a platform enabling industry peers to have in-depth discussion on the clinical application of WILLIS® to benefit more patients. During the symposium, MicroPort® NeuroTech displayed the WILLIS® simulator, and many experts, mostly those who learnt about WILLIS® for the first time, were attracted to get hands-on experience and inquire for more product information, and they were amazed by the excellent performance of WILLIS® through trying out the simulator.
Afterwards, Director Qunfu Yang of Xingtai People's Hospital, Director Zhensheng Xue of Xingtai Third Hospital, Director Zhiqiang Li of Hebei Medical University Affiliated Hospital and Director Conghui Li of Shijiazhuang First Hospital shared their clinical experience in using WILLIS®, which once again demonstrated the efficacy and safety of WILLIS® to the experts in attendance. In sum, this symposium offered the attendees a comprehensive understanding in the performance and application of WILLIS®, paving the way for MicroPort® NeuroTech to further expand the Hebei market.